| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Aug 12, 2025 | BridgeBio Pharma, Inc. | Director | Sell | 7.5 | -300,000 | -24.66% | ✓ | $13.9M |
| Feb 16, 2024 | Feb 21, 2024 | BridgeBio Pharma, Inc. | Director | Sell | 47.5 | -1,509 | -0.12% | ✗ | $56.1K |
| Nov 16, 2023 | Nov 20, 2023 | BridgeBio Pharma, Inc. | Director | Sell | 51.3 | -1,301 | -0.11% | ✗ | $37.5K |
| Aug 16, 2023 | Aug 18, 2023 | BridgeBio Pharma, Inc. | Director | Sell | 51.3 | -1,301 | -0.11% | ✗ | $38.8K |
| May 16, 2023 | May 18, 2023 | BridgeBio Pharma, Inc. | Director | Sell | 51.3 | -1,300 | -0.11% | ✗ | $18.3K |
| Feb 16, 2023 | Feb 21, 2023 | BridgeBio Pharma, Inc. | Director | Sell | 51.3 | -1,534 | -0.13% | ✗ | $19.4K |
| Nov 16, 2022 | Nov 18, 2022 | BridgeBio Pharma, Inc. | Director | Sell | 51.3 | -1,301 | -0.11% | ✗ | $12.5K |
| Aug 16, 2022 | Aug 18, 2022 | BridgeBio Pharma, Inc. | Director | Sell | 51.3 | -1,287 | -0.11% | ✗ | $14.3K |
| May 16, 2022 | May 18, 2022 | BridgeBio Pharma, Inc. | Director | Sell | 51.3 | -1,541 | -0.13% | ✗ | $10.4K |
| Mar 1, 2021 | Mar 3, 2021 | BridgeBio Pharma, Inc. | Director | Sell | 56.3 | +997 | 0.08% | ✗ | $37.7K |
| Oct 16, 2020 | Oct 19, 2020 | BridgeBio Pharma, Inc. | Chair | Sell | 45.0 | -10,256 | -0.84% | ✓ | $420.5K |
| Sep 30, 2020 | Oct 1, 2020 | BridgeBio Pharma, Inc. | Chair | Sell | 45.0 | -10,000 | -0.82% | ✓ | $380K |
| Sep 25, 2020 | Sep 29, 2020 | BridgeBio Pharma, Inc. | Chair | Sell | 23.8 | -99,257 | -7.62% | ✓ | $3.7M |
| Feb 10, 2020 | Feb 12, 2020 | BridgeBio Pharma, Inc. | Chair | Sell | 42.5 | -20,000 | -1.47% | ✓ | $720K |
| Jan 14, 2020 | Jan 16, 2020 | BridgeBio Pharma, Inc. | Chair | Sell | 45.0 | -10,000 | -0.73% | ✓ | $350K |